Sarah Boyce
Chief Executive Officer at AVIDITY BIOSCIENCES, INC.
Net worth: 3 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Foehr | M | 51 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 13 years |
| Charles Berkman | M | 55 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 23 years |
| Troy Wilson | M | 55 | 12 years | |
| Jennifer Cochran | M | 52 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| John Higgins | M | 54 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| John W. Wallen | M | 66 | 12 years | |
| Kathleen Gallagher | F | - | 3 years | |
| Eric B. Mosbrooker | M | 46 | 3 years | |
| Carolyn Bertozzi | M | 57 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Joshua Tamaroff | M | 38 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Arthur Levin | M | 70 | 11 years | |
| Steven Love | M | 55 | 1 years | |
| Noreen Henig | M | 59 | 5 years | |
| Marie-Cecile van de Lavoir | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
| Jason Haas | M | 56 | 2 years | |
| Carsten Boess | M | 57 | 4 years | |
| Tamar Thompson | F | 50 | 3 years | |
| Eric Vajda | M | - | 21 years | |
| Edward Kaye | M | 75 | 5 years | |
| Vasant Narasimhan | M | 48 | 19 years | |
| Todd Pettingill | M | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | - |
| Andrew Reardon | M | 49 | 2 years | |
| Samir Shah | M | 63 | 20 years | |
| Jean Kim | F | 50 | 3 years | |
| Kurt Gustafson | M | 56 |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | 2 years |
| Michael MacLean | M | 58 | 4 years | |
| Octavio Espinoza | M | 53 | 2 years | |
| Harry Werner Kirsch | M | 59 | 21 years | |
| Linda Armstrong | M | 61 | 17 years | |
| W. Flanagan | M | 62 | 3 years | |
| Cia McCaffrey | F | - | - | |
| Steven G. Hughes | M | 57 | 2 years | |
| Benjamin Silbert | M | 54 | - | |
| Teresa McCarthy | F | 60 | 4 years | |
| Donna Ventura | F | - | 2 years | |
| Christoper Silvia | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Howard Solomon | M | 96 | 49 years | |
| Ronen Tamir | M | 57 | - | |
| Siddhartha Kadia | M | 54 |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
| Andreas Rummelt | M | 66 | 15 years | |
| Gregory Lucier | M | 59 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
| Wendelin Wiedeking | M | 72 | 11 years | |
| Ulrich Lehner | M | 78 | 13 years | |
| Joseph Jimenez | M | 64 | 11 years | |
| Robert Dolski | M | 54 | 1 years | |
| Kurt R. Wood | M | 49 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 2 years |
| Paula Soteropoulos | F | 56 | 4 years | |
| Peter Maag | M | 56 | 5 years | |
| Jessica Hopfield | M | 59 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
| Rod Wong | M | 47 | 2 years | |
| Eric Hobbs | M | 47 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 9 years |
| Dirk van de Put | M | 63 | 1 years | |
| Juan Andres | M | 59 | 12 years | |
| Michael Martin | M | 50 | 5 years | |
| Ming C. Wu | M | 63 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 9 years |
| Damien McDevitt | M | 57 | 3 years | |
| Ambrose Bailey | M | 60 | 1 years | |
| Joshua Patterson | M | 48 | 12 years | |
| Todd Brady | M | 45 | 5 years | |
| Gerald Lieberman | M | 77 | 3 years | |
| Gary Sutton | M | - | 13 years | |
| Richard A. Moscicki | M | 72 | - | |
| Thomas Wellauer | M | 69 | - | |
| Andreas von Planta | M | 68 | - | |
| Mun Tak Yang | F | 70 | - | |
| William Brody | M | 80 | - | |
| Betsey Nelson | F | 63 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
| Michael Marks | M | 73 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | 10 years |
| John Chiminski | M | 60 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | - |
| Solomon David | M | 57 | 12 years | |
| Hans Jörg Reinhardt | M | 68 | 28 years | |
| Ann Marie Fudge | F | 72 | - | |
| Srikant T. Madhav Datar | M | 70 | 18 years | |
| Peter Hawryluk | M | 55 | 7 years | |
| Pierre Legault | M | 63 | 2 years | |
| Vincent Intrieri | M | 67 | 1 years | |
| John Kelly | M | 57 | 1 years | |
| Jürgen Brokatzky-Geiger | M | 72 | 14 years | |
| Ann Margaret Veneman | F | 74 | - | |
| Christian Mandl | M | - | 6 years | |
| Carlos Garcia-Echeverria | M | 60 | 12 years | |
| Kleem Chaudhary | M | 48 | 7 years | |
| Yuan Xu | M | 56 | 6 years | |
| Roger Sawhney | M | 54 | 3 years | |
| Joachim P. H. Schupp | M | 71 | 19 years | |
| Muriel Cottard | M | - | 14 years | |
| Ginger Gregory | M | 56 | 7 years | |
| Viviane Monges | F | 60 | 2 years | |
| Frank Bobe | M | 66 | 10 years | |
| Stefan Blarer | M | - | 10 years | |
| Jonathan Symonds | M | 66 | 5 years | |
| Vic Myer | M | - | 11 years | |
| Atul Khosia | M | - | - | |
| Argeris Karabelas | M | 71 | 2 years | |
| Jeffrey George | M | 51 | - | |
| Monika Matti | F | - | - | |
| Jessica Mann | M | - | - | |
| Sabri Markabi | M | - | - | |
| Robert Jackson | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 59 | 59.60% |
| Switzerland | 41 | 41.41% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sarah Boyce
- Personal Network
